Wredling R, Liu D, Lins P E, Adamson U
Department of Medicine, Danderyd Hospital, Sweden.
Diabete Metab. 1991 Sep-Oct;17(5):456-9.
The aim of present study was to analyse the reproducibility of plasma-free insulin profiles of subcutaneously (CSII) and intraperitoneally (CIPII) administered insulin in 6 C-peptide-negative, type 1, diabetic patients. The patients were selected for CIPII because of unsatisfactory, long-term, metabolic response to CSII. Plasma-free insulin was measured repeatedly, twice during subcutaneous infusion and twice during intraperitoneal infusion, for 4 hours, following a standard breakfast. In the CSII experiment, insulin was given as a meal-dose of 0.1 U per kg body weight, and in the CIPII experiment the meal-dose was 0.05 U per kg body weight. The dose-induced peak occurred earlier after the CIPII than with the CSII (60.0 +/- 8.0 vs 133.6 +/- 16.3 min). In conclusion, the intra-patient coefficient of variation (C.V.) of plasma-free-insulin profiles at 0-60 min and 0.240 min, as well as the peak time, were markedly lower for CIPII insulin than for CSII, indicating a more reproducible way of insulin administration with CIPII in this selected group of patients.
本研究的目的是分析6例C肽阴性的1型糖尿病患者皮下注射胰岛素(CSII)和腹腔内注射胰岛素(CIPII)后无血浆胰岛素曲线的可重复性。这些患者因对CSII的长期代谢反应不理想而被选入CIPII组。在标准早餐后4小时内,重复测量无血浆胰岛素水平,皮下输注期间测量两次,腹腔内输注期间测量两次。在CSII实验中,胰岛素以每公斤体重0.1 U的餐量给药,在CIPII实验中,餐量为每公斤体重0.05 U。CIPII给药后剂量诱导的峰值出现时间早于CSII(60.0±8.0分钟对133.6±16.3分钟)。总之,在该选定患者组中,CIPII胰岛素在0 - 60分钟和0 - 240分钟时无血浆胰岛素曲线的患者内变异系数(C.V.)以及峰值时间明显低于CSII,表明CIPII胰岛素给药方式更具可重复性。